Delivery Order SPE2DB20D6037-SPE2DB24FTUY1
- Not listed
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,692.64 contract is for the delivery of dextroamphetamine-amphetamine 10 milligram tablets, with a performance period through April 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, under which this specific delivery order was...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,690.11 contract is for the delivery of 10 mg dextroamphetamine-amphetamine capsules, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, that allows the DLA to issue delivery...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,379.38 firm-fixed-price contract is for the delivery of 4,566,357,650 units of 5 mg dextroamphetamine-amphetamine tablets, which will be completed by November 7, 2024. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The award, valued at $2,169.08, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program, a large indefinite delivery contract (IDC) worth up to $499,999,999 that runs through December 31, 2025....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,526.78 award is for the delivery of 4,558,579,566 units of the prescription drug Dextroamphetamine-Amphetamine 20 mg Capsules. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,581.84 firm fixed-price contract is for the delivery of 4,566,225,721 units of dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of October 28, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
- This federal contract award, solicited and awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.86 firm-fixed-price delivery order contract covers the provision of 4,566,975,300 units of dextroamphetamine-amphetamine 10 mg tablets. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of 10 mg tablets of the medication dextroamphetamine-amphetamine, with a ceiling value of $4,099.20. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,664.05 firm fixed-price delivery order is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets, a prescription medication, to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of 4,568,506,769 tablets of dextroamphetamine-amphetamine 20 mg to the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price, with a ceiling value of $1,734.15, and a completion date of June 11, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is awarded as a delivery order. Amerisourcebergen Drug Corp...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB24FTUY1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,169.87 firm fixed-price delivery order is for the supply of 4,563,991,991 tablets of 10 mg dextroamphetamine-amphetamine, a common prescription medication. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of various Department of Defense healthcare facilities worldwide. The contract does not have a set-aside designation. Through this award and the broader IDC, DMS Pharmaceutical Group provides both routine and critical medications, including branded, generic, and specialty drugs, to military personnel and their dependents across the Department of Defense. The company has established itself as a key supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/18/24 |